Invention Grant
- Patent Title: Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
-
Application No.: US15473008Application Date: 2017-03-29
-
Publication No.: US10017578B2Publication Date: 2018-07-10
- Inventor: Olga Ab , Daniel Tavares , Julianto Setiady , Sharron Ladd , Christina N. Carrigan , Lingyun Rui
- Applicant: ImmunoGen, Inc.
- Applicant Address: US MA Waltham
- Assignee: ImmunoGen, Inc.
- Current Assignee: ImmunoGen, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K16/30
- IPC: C07K16/30 ; G01N33/574 ; C07K16/28 ; A61K47/48 ; A61K39/00
Abstract:
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
Public/Granted literature
- US20170306041A1 ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1 Public/Granted day:2017-10-26
Information query
